Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Cites (335)

Items 201–335 of 335

1. A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
   Samit Ghosal, Debasis Datta, Binayak Sinha · 2021 · Scientific Reports
2. Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy
   Chintan V. Dave, Seoyoung C. Kim, Allison B. Goldfine, Robert J. Glynn, Angela Tong, Elisabetta Patorno · 2020 · Circulation
3. Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of healthcare interventions in primary care and community settings
   Murphy, Mark E, Byrne, Molly, Galvin, Rose, Boland, Fiona, Fahey, Tom, Smith, Susan M · 2017 · BMJ Open
4. Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial
   Clegg, Lindsay E., Penland, Robert C., Bachina, Srinivas, Boulton, David W., Thuresson, Marcus, Heerspink, Hiddo J. L., Gustavson, Stephanie, Sjöström, C. David, Ruggles, James A., Hernandez, Adrian F. et al. · 2019 · Cardiovascular Diabetology
5. Effect of regular exercise training on changes in HbA1c, BMI and VO 2 max among patients with type 2 diabetes mellitus: an 8-year trial
   Najafipour, Farzad, Mobasseri, Majid, Yavari, Abbas, Nadrian, Haidar, Aliasgarzadeh, Akbar, Mashinchi Abbasi, Naimeh, Niafar, Mitra, Houshyar Gharamaleki, Jalil, Sadra, Vahideh · 2017 · BMJ Open Diabetes Research & Care
6. The impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial
   Neeland, Ian J., Eliasson, Bjorn, Kasai, Takatoshi, Marx, Nikolaus, Zinman, Bernard, Inzucchi, Silvio E., Wanner, Christoph, Zwiener, Isabella, Wojeck, Brian S., Yaggi, Henry K. et al. · 2020 · Diabetes Care
7. Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
   Strain, W. David, Frenkel, Ofir, James, Martin A., Leiter, Lawrence A., Rasmussen, Søren, Rothwell, Peter M., Sejersten Ripa, Maria, Truelsen, Thomas C., Husain, Mansoor · 2022 · Stroke
8. Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
   for the VADT Study Group, Agrawal, Lily, Azad, Nasrin, Bahn, Gideon D., Ge, Ling, Reaven, Peter D., Hayward, Rodney A., Reda, Domenic J., Emanuele, Nicholas V. · 2018 · Diabetologia
9. Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
   Mannucci, Edoardo, Antenore, Alessandro, Giorgino, Francesco, Scavini, Marina · 2018 · Journal of Diabetes Science and Technology
10. Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development
    Konstantinou, Pinelopi, Kassianos, Angelos P, Georgiou, Giοrgos, Panayides, Andreas, Papageorgiou, Alexia, Almas, Ioannis, Wozniak, Greta, Karekla, Maria · 2020 · Translational Behavioral Medicine
11. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes
    Patrick Mahlen O'Neil, Karen Miller‐Kovach, Peter W. Tuerk, Lynne E. Becker, Thomas A. Wadden, Ken Fujioka, Priscilla L. Hollander, Robert F. Kushner, William Timothy Garvey, Domenica Rubino et al. · 2016 · Obesity
12. The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial
    Carter, S., Clifton, P.M., Keogh, J.B. · 2019 · Diabetes Research and Clinical Practice
13. Does lifestyle intervention improve health of adults with overweight/obesity and type 2 diabetes? Findings from the Look AHEAD randomized trial
    Wing, Rena R., the Look AHEAD Research Group · 2021 · Obesity
14. Switching to iGlarLixi versus continuing daily or weekly GLP-1 RA in type 2 diabetes inadequately controlled by GLP-1 RA and oral antihyperglycemic therapy: the LixiLan-G randomized clinical trial
    Blonde, Lawrence, Rosenstock, Julio, Del Prato, Stefano, Henry, Robert, Shehadeh, Naim, Frias, Juan, Niemoeller, Elisabeth, Souhami, Elisabeth, Ji, Chen, Aroda, Vanita R. · 2019 · Diabetes Care
15. Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial
    Out, Mattijs, Kooy, Adriaan, Lehert, Philippe, Schalkwijk, Casper A., Stehouwer, Coen D.A. · 2018 · Journal of Diabetes and its Complications
16. GLP‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: A systematic review and meta‐analysis
    Castellana, Marco, Cignarelli, Angelo, Brescia, Francesco, Laviola, Luigi, Giorgino, Francesco · 2019 · Diabetes/Metabolism Research and Reviews
17. Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
    Della Pepa, Giuseppe, Russo, Marco, Vitale, Marilena, Carli, Fabrizia, Vetrani, Claudia, Masulli, Maria, Riccardi, Gabriele, Vaccaro, Olga, Gastaldelli, Amalia, Rivellese, Angela A. et al. · 2021 · Diabetes Research and Clinical Practice
18. Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar
    Felicia Hill‐Briggs, Patti L. Ephraim, Elizabeth A. Vrany, Karina W. Davidson, Renée Pekmezaris, Debbie Salas‐Lopez, Catherine M. Alfano, Tiffany L. Gary‐Webb · 2022 · Current Diabetes Reports
19. Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis
    Bhattarai, Mukul, Salih, Mohsin, Regmi, Manjari, Al-Akchar, Mohammad, Deshpande, Radhika, Niaz, Zurain, Kulkarni, Abhishek, Siddique, Momin, Hegde, Shruti · 2022 · JAMA Network Open
20. Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities
    Louis Monnier, C Colette · 2006 · Diabetes & Metabolism
21. Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men
    Rådholm, Karin, Zhou, Zien, Clemens, Kristin, Neal, Bruce, Woodward, Mark · 2020 · Diabetes, Obesity and Metabolism
22. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: a systematic review and meta-analysis of randomized controlled trials
    Wang, Xue, Li, Qifei, Liu, Yan, Jiang, Hua, Chen, Wei · 2021 · Diabetes Research and Clinical Practice
23. Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial
    Pigeyre, Marie, Hess, Sibylle, Gomez, Maria F., Asplund, Olof, Groop, Leif, Paré, Guillaume, Gerstein, Hertzel · 2022 · Diabetologia
24. Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
    Furler, John, O’Neal, David, Speight, Jane, Manski-Nankervis, Jo-Anne, Gorelik, Alexandra, Holmes-Truscott, Elizabeth, Ginnivan, Louise, Young, Doris, Best, James, dean et al. · 2017 · BMJ
25. Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes
    Neuen, Brendon L., Arnott, Clare, Perkovic, Vlado, Figtree, Gemma, de Zeeuw, Dick, Fulcher, Greg, Jun, Min, Jardine, Meg J., Zoungas, Sophia, Pollock, Carol et al. · 2021 · Diabetes, Obesity and Metabolism
26. Wrist-worn accelerometers: recommending ~1.0 m g as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults
    Rowlands, Alex, Davies, Melanie, Dempsey, Paddy, Edwardson, Charlotte, Razieh, Cameron, Yates, Thomas · 2021 · British Journal of Sports Medicine
27. Lack of durable improvements in β-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes
    The RISE Consortium, Ehrmann, David A., Temple, Karla A., Rue, Abby, Barengolts, Elena, Mokhlesi, Babak, Van Cauter, Eve, Sam, Susan, Miller, M. Annette, Kahn, Steven E. et al. · 2019 · Diabetes Care
28. The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: results from the ADVANCE trial
    Nguyen, Tu N., Harris, Katie, Woodward, Mark, Chalmers, John, Cooper, Mark, Hamet, Pavel, Harrap, Stephen, Heller, Simon, MacMahon, Stephen, Mancia, Giuseppe et al. · 2021 · Diabetes Care
29. Prevalence of obstructive sleep apnea in patients with type 2 diabetes: a systematic review and meta-analysis
    Fallahi, Arezoo, Jamil, Dashty Ismil, Karimi, Elnaz Beghban, Baghi, Vajiheh, Gheshlagh, Reza Ghanei · 2019 · Diabetes & Metabolic Syndrome: Clinical Research & Reviews
30. Sex disparities in cardiovascular outcome trials of populations with diabetes: a systematic review and meta-analysis
    Clemens, Kristin K., Woodward, Mark, Neal, Bruce, Zinman, Bernard · 2020 · Diabetes Care
31. Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
    Aroda, Vanita R, González-Galvez, Guillermo, Grøn, Randi, Halladin, Natalie, Haluzík, Martin, Jermendy, György, Kok, Adri, Őrsy, Petra, Sabbah, Mohamed, Sesti, Giorgio et al. · 2019 · The Lancet Diabetes & Endocrinology
32. Digital coaching strategies to facilitate behavioral change in type 2 diabetes: a systematic review
    Gershkowitz, Bradley D, Hillert, Conor J, Crotty, Bradley H · 2021 · The Journal of Clinical Endocrinology & Metabolism
33. SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
    Dandan Li, Weilong Shi, Tiansheng Wang, Huilin Tang · 2018 · Diabetes Obesity and Metabolism
34. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
    Valentina Lukashevich, Stefano Del Prato, M. Araga, Wolfgang Kothny · 2013 · Diabetes Obesity and Metabolism
35. The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis
    Man Guo, Junling Gu, Fang‐Yuan Teng, Jiao Chen, Xiumei Ma, Qing Chen, Yueli Pu, Zongzhe Jiang, Yang Long, Yong Xu · 2020 · Endocrine
36. Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis
    Lasalvia, Pieralessandro, Barahona-Correa, Julián Esteban, Romero-Alvernia, Diana Marcela, Gil-Tamayo, Sebastián, Castañeda-Cardona, Camilo, Bayona, Juan Gabriel, Triana, Juan José, Laserna, Andrés Felipe, Mejía-Torres, Miguel, Restrepo-Jimenez, Paula et al. · 2016 · Journal of Diabetes Science and Technology
37. Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Tamara Y. Milder, SOPHIE LENA STOCKER, Christina Abdel Shaheed, Lucy McGrath‐Cadell, Dorit Samocha‐Bonet, Jerry Richard Greenfield, Richard Osborne Day · 2019 · Journal of Clinical Medicine
38. Effect of high-intensity interval training protocols on VO2max and HbA1c level in people with type 2 diabetes: a systematic review and meta-analysis
    de Mello, Mariana Brondani, Righi, Natiele Camponogara, Schuch, Felipe Barreto, Signori, Luis Ulisses, da Silva, Antônio Marcos Vargas · 2022 · Annals of Physical and Rehabilitation Medicine
39. Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
    Mottalib, Adham, Salsberg, Veronica, Mohd-Yusof, Barakatun-Nisak, Mohamed, Wael, Carolan, Padraig, Pober, David M., Mitri, Joanna, Hamdy, Osama · 2018 · Nutrition Journal
40. Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: secondary analysis of the CARMELINA randomized trial
    Perkovic, Vlado, Toto, Robert, Cooper, Mark E., Mann, Johannes F.E., Rosenstock, Julio, McGuire, Darren K., Kahn, Steven E., Marx, Nikolaus, Alexander, John H., Zinman, Bernard et al. · 2020 · Diabetes Care
41. Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
    Se Hee Min, Jeong‐Hwa Yoon, Sun Joon Moon, Seokyung Hahn, Young Min Cho · 2018 · Scientific Reports
42. Effects of sodium-glucose co-transporter 2 inhibitors on liver parameters and steatosis: a meta-analysis of randomized clinical trials
    Coelho, Francisca dos Santos, Borges‐Canha, Marta, von Hafe, Madalena, Neves, João Sérgio, Vale, Catarina, Leite, Ana Rita, Carvalho, Davide, Leite‐Moreira, Adelino · 2021 · Diabetes/Metabolism Research and Reviews
43. Pioglitazone and bariatric surgery are the most effective treatments for non-alcoholic steatohepatitis: a hierarchical network meta-analysis
    Panunzi, Simona, Maltese, Sabina, Verrastro, Ornella, Labbate, Luca, De Gaetano, Andrea, Pompili, Maurizio, Capristo, Esmeralda, Bornstein, Stefan R., Mingrone, Geltrude · 2021 · Diabetes, Obesity and Metabolism
44. Effects of intensive lifestyle intervention on all-cause mortality in older adults with type 2 diabetes and overweight/obesity: results from the Look AHEAD Study
    Look AHEAD Research Group, Wing, Rena R., Bray, George A., Cassidy-Begay, Maria, Clark, Jeanne M., Coday, Mace, Egan, Caitlin, Evans, Mary, Foreyt, John P., Glasser, Stephen et al. · 2022 · Diabetes Care
45. The impact of a self-management educational program coordinated through WhatsApp on diabetes control
    Al Omar, Muaed, Hasan, Sanah, Palaian, Subish, Mahameed, Shrouq · 2020 · Pharmacy Practice
46. Canagliflozin and kidney-related adverse events in type 2 diabetes and CKD: findings from the randomized CREDENCE trial
    Heerspink, Hiddo J.L., Oshima, Megumi, Zhang, Hong, Li, Jingwei, Agarwal, Rajiv, Capuano, George, Charytan, David M., Craig, Jagriti, de Zeeuw, Dick, Di Tanna, Gian Luca et al. · 2022 · American Journal of Kidney Diseases
47. The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression
    Hangaard, Stine, Laursen, Sisse H., Andersen, Jonas D., Kronborg, Thomas, Vestergaard, Peter, Hejlesen, Ole, Udsen, Flemming W. · 2023 · Journal of Diabetes Science and Technology
48. Triple therapy in type 2 diabetes; a systematic review and network meta-analysis
    Martin Downes, Emilie K. Bettington, Jenny Elizabeth Gunton, Erika Turkstra · 2015 · PeerJ
49. Durability of triple combination therapy versus stepwise addition therapy in patients with new-onset T2DM: 3-year follow-up of EDICT
    Abdul-Ghani, Muhammad, Puckett, Curtiss, Adams, John, Khattab, Ahmad, Baskoy, Gozde, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A. · 2021 · Diabetes Care
50. A1C targets should be personalized to maximize benefits while limiting risks
    Riddle, Matthew C., Gerstein, Hertzel C., Holman, Rury R., Inzucchi, Silvio E., Zinman, Bernard, Zoungas, Sophia, Cefalu, William T. · 2018 · Diabetes Care
51. Physical behaviors and chronotype in people with type 2 diabetes
    Joseph J. Henson, Alex V. Rowlands, Emma L. Baldry, Emer M. Brady, Melanie Jane Davies, Charlotte Louise Edwardson, Thomas E. Yates, Andrew P. Hall · 2020 · BMJ Open Diabetes Research & Care
52. Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials
    Jack Alistair Sargeant, Emer M. Brady, Francesco Zaccardi, Frances Tippins, David R. Webb, Vanita R. Aroda, Edward W. Gregg, Kamlesh Khunti, Melanie Jane Davies · 2020 · Diabetologia
53. Physical function following a long-term lifestyle intervention among middle aged and older adults with type 2 diabetes: the Look AHEAD study
    Houston, Denise K, Neiberg, Rebecca H, Miller, Michael E, Hill, James O, Jakicic, John M, Johnson, Karen C, Gregg, Edward W, Hubbard, Van S, Pi-Sunyer, Xavier, Rejeski, W Jack et al. · 2018 · The Journals of Gerontology: Series A
54. Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Maiorino, Maria Ida, Chiodini, Paolo, Bellastella, Giuseppe, Scappaticcio, Lorenzo, Longo, Miriam, Esposito, Katherine, Giugliano, Dario · 2018 · Diabetes, Obesity and Metabolism
55. Type 2 diabetes and impaired physical function: a growing problem
    Ahmad, Ehtasham, Sargeant, Jack A., Yates, Tom, Webb, David R., Davies, Melanie J. · 2022 · Diabetology
56. Structured lifestyle intervention based on a trans-cultural diabetes-specific nutrition algorithm (tDNA) in individuals with type 2 diabetes: a randomized controlled trial
    Winnie SS Chee, Harvinder Kaur Gilcharan Singh, Osama Hamdy, Jeffrey Ian Mechanick, Verna K. M. Lee, Ankur Barua, Siti Zubaidah Mohd Ali, Zanariah Binti Hussein · 2017 · BMJ Open Diabetes Research & Care
57. SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review
    Dwinata, Michael, Putera, David, Hasan, Irsan, Raharjo, Monica · 2020 · Clinical and Experimental Hepatology
58. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
    Antonio Nicolucci, Antonio Ceriello, Paolo Di Bartolo, Antonella Corcos, Marco Orsini Federici · 2019 · Diabetes Therapy
59. Web-based interventions for dietary behavior in adults with type 2 diabetes: systematic review of randomized controlled trials
    Dening, Jedha, Islam, Sheikh Mohammed Shariful, George, Elena, Maddison, Ralph · 2020 · Journal of Medical Internet Research
60. Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes: Insights From the STAMPEDE Randomized Trial
    Aminian, Ali, Kashyap, Sangeeta R., Wolski, Kathy E., Brethauer, Stacy A., Kirwan, John P., Nissen, Steven E., Bhatt, Deepak L., Schauer, Philip R. · 2021 · Annals of Surgery
61. A randomized controlled trial of the efficacy and safety of saxagliptin as add‐on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
    Robert Geoffrey Moses, Sanjay Kalra, D. Brook, Jim Sockler, John T. Monyak, Jayanti Visvanathan, M. Montanaro, S. A. Fisher · 2013 · Diabetes Obesity and Metabolism
62. Frequency of interruptions to sitting time: benefits for postprandial metabolism in type 2 diabetes
    Homer, Ashleigh R., Taylor, Frances C., Dempsey, Paddy C., Wheeler, Michael J., Sethi, Parneet, Townsend, Melanie K., Grace, Megan S., Green, Daniel J., Cohen, Neale D., Larsen, Robyn N. et al. · 2021 · Diabetes Care
63. Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice
    Lutz Heinemann, Christopher G. Parkin · 2018 · Journal of Diabetes Research
64. Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes
    Anastasia‐Vasiliki Madenidou, Paschalis Paschos, Thomas Karagiannis, Anastasia Katsoula, Eleni A. Athanasiadou, Konstantinos Kitsios, Eleni Bekiari, David Richard Matthews, Απόστολος Τσάπας · 2018 · Annals of Internal Medicine
65. Efficacy and safety of initial combination therapy in treatment-naïve type 2 diabetes patients: a systematic review and meta-analysis
    Cai, Xiaoling, Gao, Xueying, Yang, Wenjia, Han, Xueyao, Ji, Linong · 2018 · Diabetes Therapy
66. Effects of liraglutide on cardiovascular outcomes in type 2 diabetes patients with and without baseline metformin use: post hoc analyses of the LEADER trial
    Crowley, Matthew J., McGuire, Darren K., Alexopoulos, Anastasia-Stefania, Jensen, Thomas Jon, Rasmussen, Søren, Saevereid, Hans A., Verma, Subodh, Buse, John B. · 2020 · Diabetes Care
67. Dose-dependent effect of supervised aerobic exercise on HbA1c in patients with type 2 diabetes: a meta-analysis of randomized controlled trials.
    Jayedi, Ahmad, Emadi, Alireza, Shab-Bidar, Sakineh · 2022 · Sports Medicine
68. Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta‐analysis
    Elizabeth S. Mearns, Whitney J Saulsberry, Charles Michael White, Christine G. Kohn, Simone Lemieux, A. Sihabout, I. Salamucha, Craig Ian Coleman · 2015 · Diabetic Medicine
69. The role of aerobic training variables progression on glycemic control of patients with type 2 diabetes: a systematic review with meta-analysis
    Delevatti, Rodrigo Sudatti, Bracht, Cláudia Gomes, Lisboa, Salime Donida Chedid, Costa, Rochelle Rocha, Marson, Elisa Corrêa, Netto, Nathalie, Kruel, Luiz Fernando Martins · 2019 · Sports Medicine - Open
70. Impact of technology on glycaemic control in type 2 diabetes: A meta‐analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion
    Ilaria Dicembrini, Edoardo Mannucci, Matteo Monami, Laura Pala · 2019 · Diabetes Obesity and Metabolism
71. Metabolic surgery for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials
    Cresci, Barbara, Cosentino, Claudia, Monami, Matteo, Mannucci, Edoardo · 2020 · Diabetes, Obesity and Metabolism
72. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature
    Mistry, Serena, Eschler, Deirdre Cocks · 2021 · AACE Clinical Case Reports
73. Impact of DSMES app interventions on medication adherence in type 2 diabetes mellitus: systematic review and meta-analysis
    Enricho Nkhoma, Dumisani, Jenya Soko, Charles, Joseph Banda, Kondwani, Greenfield, David, Li, Yu-Chuan (Jack), Iqbal, Usman · 2021 · BMJ Health & Care Informatics
74. A randomized controlled study comparing a DPP4 inhibitor (linagliptin) and basal insulin (glargine) in patients with type 2 diabetes in long-term care and skilled nursing facilities: linagliptin-LTC trial
    Umpierrez, Guillermo E., Cardona, Saumeth, Chachkhiani, David, Fayfman, Maya, Saiyed, Sahebi, Wang, Heqiong, Vellanki, Priyathama, Haw, J. Sonya, Olson, Darin E., Pasquel, Francisco J. et al. · 2018 · Journal of the American Medical Directors Association
75. SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews
    Shao, Shih-Chieh, Kuo, Liang-Tseng, Chien, Rong-Nan, Hung, Ming-Jui, Lai, Edward Chia-Cheng · 2020 · BMJ Open Diabetes Research & Care
76. Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
    Huber, Carola A, Reich, Oliver · 2016 · Patient Preference and Adherence
77. S odium‐glucose co‐transporter‐2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis
    Dario Giugliano, Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito · 2021 · Diabetes Obesity and Metabolism
78. Network meta-analysis of metabolic surgery procedures for the treatment of obesity and diabetes
    Currie, Andrew C., Askari, Alan, Fangueiro, Ana, Mahawar, Kamal · 2021 · Obesity Surgery
79. Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
    Wojeck, Brian S., Inzucchi, Silvio E., Neeland, Ian J., Mancuso, James P., Frederich, Robert, Masiukiewicz, Urszula, Cater, Nilo B., McGuire, Darren K., Cannon, Christopher P., Yaggi, Henry Klar · 2023 · Sleep and Breathing
80. Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
    Richard M. Bergenstal, Mark F. Peyrot, Darlene M. Dreon, Vanita R. Aroda, Timothy Silleck Bailey, Ronald Brazg, Juan P. Frías, Mary Lynn Johnson, David Charles Klonoff, Davida F. Kruger et al. · 2019 · Diabetes Technology & Therapeutics
81. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis
    Dorsey-Treviño, E. G., González-González, J. G., Alvarez-Villalobos, N., González-Nava, V., Contreras-Garza, B. M., Díaz González-Colmenero, A., Rodríguez-Tamez, G., Barrera-Flores, F. J., Farrell, A. M., Montori, V. M. et al. · 2020 · Journal of Endocrinological Investigation
82. Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials
    Sophie Sun, Lucie Hisland, Guillaume Grenet, François Gueyffier, Catherine Cornu, Némat Jaafari, Rémy Boussageon · 2021 · Therapies
83. Effect of Telemetric Interventions on Glycated Hemoglobin A1c and Management of Type 2 Diabetes Mellitus: Systematic Meta-Review
    Eberle, Claudia, Stichling, Stefanie · 2021 · Journal of Medical Internet Research
84. Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58
    Avivit Cahn, Itamar Raz, Lawrence A. Leiter, Ofri Mosenzon, Sabina A. Murphy, Erica L. Goodrich, Ilan Yanuv, Aliza Rozenberg, Deepak L. Bhatt, Darren K. McGuire et al. · 2021 · Diabetes Care
85. Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
    SABINE KAHL, Anne Pernille Ofstad, Bernard Zinman, Christoph Wanner, Elke Schueler, Naveed A. Sattar, Silvio E. Inzucchi, Michael Roden · 2022 · Diabetes Obesity and Metabolism
86. Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies
    Crabtree, Thomas, Ogendo, Jael-Joy, Vinogradova, Yana, Gordon, Jason, Idris, Iskandar · 2022 · Expert Review of Endocrinology & Metabolism
87. Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis
    Crystal Lee, Mark Woodward, Stephen Colagiuri · 2016 · Diabetes Research and Clinical Practice
88. The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes
    Dalsgaard, Niels B, Gasbjerg, Lærke S, Hansen, Laura S, Hansen, Nina L, Stensen, Signe, Hartmann, Bolette, Rehfeld, Jens F, Holst, Jens J, Vilsbøll, Tina, Knop, Filip K · 2021 · European Journal of Endocrinology
89. Novel antidiabetic drugs and risk of cardiovascular events in patients without baseline metformin use: a meta-analysis
    Masson, Walter, Lavalle-Cobo, Augusto, Lobo, Martín, Masson, Gerardo, Molinero, Graciela · 2021 · European Journal of Preventive Cardiology
90. Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial
    Lee, Matthew M.Y., Kristensen, Søren L., Gerstein, Hertzel C., McMurray, John J.V., Sattar, Naveed · 2022 · Diabetes & Metabolic Syndrome: Clinical Research & Reviews
91. Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial
    Barraclough, Jennifer Y., Yu, Jie, Figtree, Gemma A., Perkovic, Vlado, Heerspink, Hiddo J. L., Neuen, Brendon L., Cannon, Christopher P., Mahaffey, Kenneth W., Schutte, Aletta E., Neal, Bruce et al. · 2022 · Diabetes, Obesity and Metabolism
92. The effect of nurse prescribers on glycaemic control in type 2 diabetes: a systematic review and meta-analysis
    Tabesh, Maryam, Magliano, Dianna J., Koye, Digsu N., Shaw, Jonathan E. · 2018 · International Journal of Nursing Studies
93. Insights from VERIFY: early combination therapy provides better glycaemic durability than a stepwise approach in newly diagnosed type 2 diabetes
    Matthews, David, Del Prato, Stefano, Mohan, Viswanathan, Mathieu, Chantal, Vencio, Sergio, Chan, Juliana C. N., Stumvoll, Michael, Paldánius, Päivi Maria · 2020 · Diabetes Therapy
94. A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
    Robert Geoffrey Moses, Elizabeth Round, Yue Shentu, Gregory T. Golm, Edward A. O’Neill, Ira Gantz, Samuel S. Engel, Keith D. Kaufman, Barry J. Goldstein · 2015 · Journal of Diabetes
95. Efficacy and safety of combination therapy with an α‐glucosidase inhibitor and a dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta‐analysis
    Se Hee Min, Jeong‐Hwa Yoon, Seokyung Hahn, Young Min Cho · 2017 · Journal of Diabetes Investigation
96. Do GLP‐1RAs and SGLT‐2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis
    Basem M. Mishriky, James R. Powell, Jennifer A. Wittwer, Jennifer Chu, Kerry B. Sewell, Qiang Wu, Doyle M. Cummings · 2019 · Diabetes Obesity and Metabolism
97. Comparison of glucose‐lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials
    Francesco Zaccardi, Nafeesa N Dhalwani, Jolyon Dales, Hamidreza Mani, Kamlesh Khunti, Melanie Jane Davies, David R. Webb · 2017 · Diabetes Obesity and Metabolism
98. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
    Jalaludin, Muhammad Yazid, Deeb, Asma, Zeitler, Philip, Garcia, Raymundo, Newfield, Ron S., Samoilova, Yulia, Rosario, Carmen A., Shehadeh, Naim, Saha, Chandan K., Zhang, Yilong et al. · 2022 · Pediatric Diabetes
99. Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study
    Juliana C.N. Chan, Päivi Maria Paldánius, Chantal Mathieu, Michael Stümvoll, David Richard Matthews, Stefano Del Prato · 2020 · Diabetes Obesity and Metabolism
100. Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials
     Mannucci, Edoardo, Caiulo, Chiara, Naletto, Lara, Madama, Giuseppe, Monami, Matteo · 2021 · Endocrine
101. Device‐measured physical activity and its association with physical function in adults with type 2 diabetes mellitus
     Monika Mickute, Joseph J. Henson, Alex V. Rowlands, Jack Alistair Sargeant, David R. Webb, Andrew P. Hall, Charlotte Louise Edwardson, Emma L. Baldry, Emer M. Brady, Kamlesh K. Khunti et al. · 2020 · Diabetic Medicine
102. GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials
     Tsapas, Apostolos, Karagiannis, Thomas, Avgerinos, Ioannis, Liakos, Aris, Bekiari, Eleni · 2021 · Diabetes Research and Clinical Practice
103. Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management
     Smyth, Aisling, Jenkins, Mark, Dunham, Melissa, Kutzer, Yvonne, Taheri, Shahrad, Whitehead, Lisa · 2020 · Diabetes Research and Clinical Practice
104. Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery
     Russo, Maria Francesca, Lembo, Erminia, Mari, Andrea, Angelini, Giulia, Verrastro, Ornella, Nanni, Giuseppe, Pompili, Maurizio, Raffaelli, Marco, Vecchio, Fabio Maria, Bornstein, Stefan R et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
105. Insulin discovery: A pivotal point in medical history
     Pierpaolo Falcetta, Michele Aragona, Alessandra Bertolotto, Cristina Bianchi, Fabrizio Campi, Monia Garofolo, Stefano Del Prato · 2021 · Metabolism
106. A novel user utility score for diabetes management using tailored mobile coaching: secondary analysis of a randomized controlled trial
     Lee, Min-Kyung, Lee, Da Young, Ahn, Hong-Yup, Park, Cheol-Young · 2021 · JMIR mHealth and uHealth
107. Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa
     Michelle Lowe, Ashika Singh-Moodley, Husna Ismail, Teena Thomas, Vindana Chibabhai, Trusha Nana, Warren Lowman, Arshad Ismail, Wai Yin Chan, Olga Perovic · 2022 · Frontiers in Microbiology
108. Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes
     Jens Sandahl Christiansen, LEO K. NISKANEN, Søren Rasmussen, Thue Johansen, Greg Fulcher · 2015 · Journal of Diabetes
109. Inhaled Insulin
     Jason Chan, Angela Cheng-Lai · 2017 · Cardiology in Review
110. Effect of tai chi on glycaemic control, lipid metabolism and body composition in adults with type 2 diabetes: a meta-analysis and systematic review
     Guo, S, Xu, Y, Qin, J, Chen, Y, You, Y, Tao, J, Liu, Z, Huang, J · 2021 · Journal of Rehabilitation Medicine
111. Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m2?: a Meta-analysis
     Matilde Rubio-Almanza, David Hervás, Rosa Cámara-Gómez, Jana Caudet-Esteban, Juan Francisco Merino-Torres · 2019 · Obesity Surgery
112. Effectiveness of yoga-based exercise program compared to usual care, in improving HbA1c in individuals with type 2 diabetes: a randomized control trial
     Tandon, Nikhil, Gupta, Uttio, Gupta, Yashdeep, Jose, Divya, Mani, Kalaivani, Jyotsna, VivekaP, Sharma, Gautam · 2020 · International Journal of Yoga
113. Diabetes: how to manage patients experiencing hypoglycaemia
     Rachel N. Lowe, Briana Williams, Liza W. Claus · 2022 · Drugs in Context
114. Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials
     Qian, B-B., Chen, Q., Li, L., Yan, C-F. · 2020 · Osteoporosis International
115. Preoperative bariatric surgery predictors of type 2 diabetes remission
     Fultang, Joshua, Chinaka, Ugochukwu, Rankin, Jean, Bakhshi, Andisheh, Ali, Abdulmajid · 2021 · Journal of Obesity & Metabolic Syndrome
116. Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic
     Quinn, Lauren M., Davies, Melanie J., Northern, Alison, Brough, Chris, Schreder, Sally, Stribling, Bernie, Khunti, Kamlesh, Hadjiconstantinou, Michelle · 2021 · Diabetic Medicine
117. Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial
     A-Rum Hong, Jeun Lee, Eu Jeong Ku, Yul Hwangbo, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang, Soo Kyung Lim · 2015 · Diabetes Research and Clinical Practice
118. Safety and tolerability of glucagon-like peptide-1 receptor agonists utilizing data from the exenatide clinical trial development program
     Peng, Hui, Want, Laura L., Aroda, Vanita R. · 2016 · Current Diabetes Reports
119. Polydatin activates the Nrf2/HO-1 signaling pathway to protect cisplatin-induced hearing loss in guinea pigs
     Dafei Li, Haiyan Zhao, Piao Xu, Qiongping Lin, Tingting Zhao, Chubing Li, Zhong‐Kai Cui, Guangyong Tian · 2022 · Frontiers in Pharmacology
120. Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
     Husain, Mansoor, Consoli, Agostino, De Remigis, Alessandra, Pettersson Meyer, Anna Sina, Rasmussen, Søren, Bain, Stephen · 2022 · Cardiovascular Diabetology
121. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial
     Manski-Nankervis, Jo-Anne, Furler, John, O’Neal, David, Ginnivan, Louise, Thuraisingam, Sharmala, Blackberry, Irene · 2017 · Primary Care Diabetes
122. Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients
     Barakatun Nisak Mohd Yusof, Wan Zul Haikal Hafiz Wan Zukiman, Zalina Abu Zaid, Noraida Omar, Firdaus Mukhtar, Nor Farahain Yahya, Aainaa Syarfa Mohd Shahar, Farah Yasmin Hasbullah, Rachel Liu Xin Yi, Agnieszka M. Marczewska et al. · 2020 · Nutrients
123. Insulin/glucagon-like peptide-1 receptor agonist combination therapy for the treatment of type 2 diabetes: are two agents better than one?
     Aroda, Vanita R., Arulandu, Joseph R., Cannon, Anthony J. · 2018 · Clinical Diabetes
124. Comparison of glycemic excursion using flash continuous glucose monitoring in patients with type 2 diabetes mellitus before and after treatment with voglibose
     Kasthuri, Selvam, Poongothai, Subramani, Anjana, Ranjit Mohan, Selvakumar, Jayvel, Muthukumar, Subramaniam, Kayalvizhi, Sengottuevel, Tariq, Syed, Honey, Evangelin, Gupta, Prasanna Kumar, Venkatesan, Ulagamathesan et al. · 2021 · Diabetes Technology & Therapeutics
125. Long-term health benefits of intensive lifestyle intervention in the Look AHEAD study
     Garvey, W. Timothy · 2021 · Obesity
126. Comparative effectiveness of bariatric surgeries in patients with type 2 diabetes mellitus and BMI ≥ 25 kg/m2: a systematic review and network meta-analysis
     Carmona, Maria Neves, Santos-Sousa, Hugo, Lindeza, Luís, Sousa-Pinto, Bernardo, Nogueiro, Jorge, Pereira, André, Carneiro, Silvestre, Costa-Pinho, André, Lima-da-Costa, Eduardo, Preto, John et al. · 2021 · Obesity Surgery
127. Comparison of glycemic variability and hypoglycemic events in hospitalized older adults treated with basal insulin plus vildagliptin and basal-bolus insulin regimen: a prospective randomized study
     Batule, Sol, Ramos, Analía, Pérez-Montes de Oca, Alejandra, Fuentes, Natalia, Martínez, Santiago, Raga, Joan, Pena, Xoel, Tural, Cristina, Muñoz, Pilar, Soldevila, Berta et al. · 2022 · Journal of Clinical Medicine
128. Changes in dietary intake improve glycemic control following a structured nutrition therapy during Ramadan in individuals with type 2 diabetes
     Barakatun Nisak Mohd Yusof, Farah Yasmin Hasbullah, Aainaa Syarfa Mohd Shahar, Noraida Omar, Zalina Abu Zaid, Firdaus Mukhtar, Rachel Xin Yi Liu, Agnieszka M. Marczewska, Osama Hamdy · 2021 · Clinical Nutrition ESPEN
129. The Impact of Shift Work on Diabetes Self-Management Activities
     Daniel J. Navarro, Patricia T. Alpert, Chad Lee Cross · 2019 · Journal of Doctoral Nursing Practice
130. Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
     Niki Katsiki, Richard Ofori‐Asenso, Ele Ferrannini, Mohsen Mazidi · 2020 · Diabetes Obesity and Metabolism
131. Rationality, Efficacy, Tolerability of Empagliflozin Plus Linagliptin Combination for the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials and Observational Studies
     Santenna Chenchula, Shoban Babu Varthya, R. Padmavathi · 2021 · Current Diabetes Reviews
132. Glucagon-like peptide-1 receptor agonists and cardioprotective benefit in patients with type 2 diabetes without baseline metformin: a systematic review and update meta-analysis
     Lavalle-Cobo, Augusto, Masson, Walter, Lobo, Martín, Masson, Gerardo, Molinero, Graciela · 2021 · High Blood Pressure & Cardiovascular Prevention
133. Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
     Maximilian Gabler, Nils Picker, Silke Geier, Johannes Foersch, Jens Aberle, Stéphan Martin, Matthias Riedl, Thomas Wilke · 2021 · Diabetes Research and Clinical Practice
134. Manufacturing with pluripotent stem cells ( PSConf 2021): Key issues for future research and development
     Glyn Nigel Stacey, Jingyi Cao, Baoyang Hu · 2022 · Cell Proliferation
135. Efficacy and Safety of Basal Insulin/GLP-1 Receptor Agonist Used in Combination for Type 2 Diabetes Management
     Delilah J. McCarty, Alaina Olenik, Bryan P. McCarty · 2018 · Journal of Pharmacy Practice